Drug industry
Article Abstract:
Stock prices for the US drug industry have remained strong in the first half of the year 2001, with many at all-time highs. Product demand is keeping profits healthy, but there are some problems with several companies. This industry's stocks are timely for investors in 2001.
Author: Rho, George, Jones, Stephen E., Ferro, Mario, Romaine, Sigourney B., Schlein, Milton, Feenan, Gerard, Harris, Frederick L., III, Clark, Charles, Gallen, David, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Ferrara, J. Susan, Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2001
Andre Group
Drug industry
Article Abstract:
The pharmaceuticals industry has done well in the year 2001 in spite of the slower US economy and the Sep 11, 2001 terrorist attacks. However, the lapse of patents presents a challenge to many drug companies. These stocks are timely for 2001 and the next three to five years.
Author: Rho, George, Jones, Stephen E., Ferro, Mario, Romaine, Sigourney B., Schlein, Milton, Feenan, Gerard, Clark, Charles, Gallen, David, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Ferrara, J. Susan, Chow, Nancy, Harris, Frederick L. III
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2001
Drugs & Pharmaceuticals, Biochemistry, Pharmaceutical and Medicine Manufacturing, Research and Development in the Physical, Engineering, and Life Sciences, Switzerland, Ireland, Belgium, Vaccines & Antigens for Human Use, Biological Product (except Diagnostic) Manufacturing, Drugs, Biological Products, In-Vitro Diagnostic Substance Manufacturing, Biological products exc. diagnostic, Diagnostic substances, Drugs and Druggists' Sundries Wholesalers, Drugs, proprietaries, and sundries, Drugs, Cosmetics, Toiletries Whsle, Diagnostic Reagents, Biotechnology industry, Biotechnology industries, Wholesale industry, Wholesale trade, Vaccines industry, Biological products industry, Diagnostic reagents industry, Health products industry, Health care products industry, Andrx Corp., ADRX
Subjects list: Statistical Data Included, United States, Industry Overview, Pharmaceutical industry, Drugs, Novartis AG, Securities, Eli Lilly and Co., Pfizer Inc., PNU, Bristol-Myers Squibb Co., Chiron Corp., Covance Inc., Cygnus Inc., Elan Corporation PLC, Forest Laboratories Inc., Genzyme Corp., Gilead Sciences Inc., IDEC Pharmaceuticals Corp., Inhale Therapeutic Systems Inc., IVAX Corp., MedImmune Inc., Mylan Laboratories Inc., PAREXEL International Corp., Perrigo Co., Pharmaceutical Product Development Inc., Quintiles Transnational Corp., Schering-Plough Corp., Sicor Inc., Watson Pharmaceuticals Inc., AHP, BRL, BMY, CHIR, CVD, CYGN, ELN, FRX, GENZ, GILD, ICN, IDPH, INHL, IVX, LLY, MEDI, MLY, PRXL, PRGO, PFE, PPDI, QTRN, SGP, WPI, Pharmacia Corp., ImClone Systems Inc., Sepracor Inc., Cephalon Inc., CEPH, SEPR, Biovail Corp., GlaxoSmithKline Inc., Valeant Pharmaceuticals International, Wyeth, Merck & Company Inc., NVTSY, Medarex Inc., MEDX, Protein Design Labs Inc., PDLI, Barr Laboratories Inc., Abgenix Inc., King Pharmaceuticals Inc., Medicis Pharmaceutical Corp., ABGX, IMCL, MDRXD
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
